Medical Cash Per Share vs Book Value Per Share Analysis
MPW Stock | USD 4.78 0.27 5.99% |
Medical Properties financial indicator trend analysis is infinitely more than just investigating Medical Properties Trust recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Medical Properties Trust is a good investment. Please check the relationship between Medical Properties Cash Per Share and its Book Value Per Share accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medical Properties Trust. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
Cash Per Share vs Book Value Per Share
Cash Per Share vs Book Value Per Share Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Medical Properties Trust Cash Per Share account and Book Value Per Share. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Medical Properties' Cash Per Share and Book Value Per Share is 0.56. Overlapping area represents the amount of variation of Cash Per Share that can explain the historical movement of Book Value Per Share in the same time period over historical financial statements of Medical Properties Trust, assuming nothing else is changed. The correlation between historical values of Medical Properties' Cash Per Share and Book Value Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash Per Share of Medical Properties Trust are associated (or correlated) with its Book Value Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Book Value Per Share has no effect on the direction of Cash Per Share i.e., Medical Properties' Cash Per Share and Book Value Per Share go up and down completely randomly.
Correlation Coefficient | 0.56 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Cash Per Share
Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Most indicators from Medical Properties' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medical Properties Trust current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medical Properties Trust. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. At this time, Medical Properties' Selling General Administrative is fairly stable compared to the past year. Enterprise Value is likely to climb to about 4.2 B in 2024, despite the fact that Discontinued Operations is likely to grow to (855.00).
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.5B | 1.5B | 830.2M | 537.8M | Total Revenue | 1.5B | 1.5B | 871.8M | 549.6M |
Medical Properties fundamental ratios Correlations
Click cells to compare fundamentals
Medical Properties Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Medical Properties fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 14.5B | 16.8B | 20.5B | 19.7B | 18.3B | 19.2B | |
Accounts Payable | (107.9M) | 387.5M | 603.6M | 621.3M | 412.2M | 432.8M | |
Cash | 1.5B | 549.9M | 459.2M | 235.7M | 250.0M | 258.7M | |
Other Assets | 1.5B | 15.0B | 3.9B | 632.6M | 16.3B | 17.2B | |
Total Liab | 7.4B | 9.5B | 12.1B | 11.1B | 10.7B | 11.2B | |
Common Stock | 371K | 518K | 541K | 597K | 599K | 629.0K | |
Short Long Term Debt Total | 7.1B | 9.0B | 11.4B | 11.3B | 10.2B | 10.7B | |
Total Stockholder Equity | 7.0B | 7.3B | 8.4B | 8.6B | 7.6B | 8.0B | |
Other Liab | 45.7M | 180.9M | 183.6M | 70.3M | 80.9M | 61.7M | |
Net Debt | 5.7B | 8.5B | 11.0B | 11.1B | 9.9B | 10.4B | |
Retained Earnings | 83.0M | (71.4M) | (87.7M) | 116.3M | (971.8M) | (923.2M) | |
Non Current Assets Total | 12.1B | 14.9B | 17.9B | 18.2B | 16.9B | 17.8B | |
Non Currrent Assets Other | 10.5B | 12.5B | 15.3B | (12.4B) | 109.0M | 114.5M | |
Long Term Debt | 7.0B | 8.9B | 11.3B | 10.3B | 8.5B | 9.0B | |
Cash And Short Term Investments | 1.5B | 549.9M | 459.2M | 235.7M | 250.0M | 271.7M | |
Net Receivables | 910.4M | 1.4B | 2.1B | 1.2B | 681.0M | 424.2M | |
Common Stock Total Equity | 371K | 518K | 541K | 597K | 686.6K | 720.9K | |
Common Stock Shares Outstanding | 428.3M | 530.5M | 590.1M | 598.8M | 598.5M | 628.4M | |
Liabilities And Stockholders Equity | 14.5B | 16.8B | 20.5B | 19.7B | 18.3B | 19.2B | |
Non Current Liabilities Total | 7.1B | 9.0B | 11.4B | 10.4B | 8.7B | 9.1B | |
Other Stockholder Equity | 7.0B | 7.5B | 8.6B | 8.5B | 8.6B | 9.0B | |
Total Current Assets | 2.4B | 1.9B | 2.6B | 1.4B | 1.4B | 1.3B | |
Accumulated Other Comprehensive Income | (62.9M) | (51.3M) | (36.7M) | (59.2M) | 42.5M | 44.6M | |
Other Current Liab | 291.5M | (114.1M) | (1.6B) | (929.6M) | 1.1B | 1.1B | |
Total Current Liabilities | 307.6M | 474.9M | 633.4M | 649.1M | 2.0B | 2.1B | |
Current Deferred Revenue | 16.1M | 36.2M | 25.6M | 27.7M | 38.0M | 36.1M | |
Other Current Assets | (1.8B) | (1.1B) | (1.2B) | 304.5M | (931.1M) | (884.5M) | |
Short Term Debt | 107.9M | 165.4M | 1.6B | 929.6M | 463.1M | 569.5M | |
Intangible Assets | 622.1M | 1.3B | 1.4B | 1.4B | 1.0B | 983.1M | |
Inventory | 1.8B | 1.0 | 1.2B | (304.5M) | (43.0M) | (40.8M) | |
Net Tangible Assets | 6.4B | 6.0B | 8.4B | 7.2B | 8.3B | 4.3B | |
Noncontrolling Interest In Consolidated Entity | 107K | 5.3M | 5.5M | 1.6M | 1.4M | 1.3M | |
Retained Earnings Total Equity | 83.0M | (71.4M) | (87.7M) | 116.3M | 104.7M | 109.9M | |
Long Term Debt Total | 7.0B | 8.9B | 11.3B | 10.3B | 11.8B | 12.4B | |
Capital Surpluse | 7.0B | 7.5B | 8.6B | 8.5B | 9.8B | 5.1B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medical Properties Trust. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Medical Stock analysis
When running Medical Properties' price analysis, check to measure Medical Properties' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Properties is operating at the current time. Most of Medical Properties' value examination focuses on studying past and present price action to predict the probability of Medical Properties' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Properties' price. Additionally, you may evaluate how the addition of Medical Properties to your portfolios can decrease your overall portfolio volatility.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Transaction History View history of all your transactions and understand their impact on performance | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Medical Properties' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medical Properties. If investors know Medical will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medical Properties listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.49) | Dividend Share 0.88 | Earnings Share (0.93) | Revenue Per Share 1.48 | Quarterly Revenue Growth (0.13) |
The market value of Medical Properties Trust is measured differently than its book value, which is the value of Medical that is recorded on the company's balance sheet. Investors also form their own opinion of Medical Properties' value that differs from its market value or its book value, called intrinsic value, which is Medical Properties' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medical Properties' market value can be influenced by many factors that don't directly affect Medical Properties' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medical Properties' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medical Properties is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medical Properties' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.